Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Biological Chemistry

Propofol Derivative May Pave The Way For Improved Anesthetics

Researchers use light-activated analog to find where the molecule binds ion-channel target

by Carmen Drahl
September 30, 2013 | A version of this story appeared in Volume 91, Issue 39

[+]Enlarge
Credit: Courtesy of Nicholas Franks
This computer model indicates the proposed binding site for the anesthetic propofol (sticks) in the ion channel known as the GABAA receptor (ribbon)
Credit: Courtesy of Nicholas Franks

The intravenous drug propofol is one of the most common anesthetics used in surgery. It’s popular because it rarely causes nausea and is fast-acting, but it can cause unwanted side effects such as low blood pressure and breathing problems. Researchers seek a next-generation propofol derivative that induces unconsciousness without any side effects, but they lack exact information about how the drug works. Now, one group of scientists say they’ve uncovered propofol’s binding site at its most important protein target, an ion channel called the GABAA receptor (Nat. Chem. Biol. 2013, DOI: 10.1038/nchembio.1340). Prior studies pointed to a propofol-binding site between subunits of the ion channel, but much of the evidence was indirect. Nicholas P. Franks of Imperial College London, Alex S. Evers of Washington University School of Medicine, in St. Louis, and colleagues report that the site is instead at the interface between the membrane-spanning part of the channel and its extracellular domain. They detected this site by developing a light-activated labeling reagent, o-propofol diazirine, with similar biological activity as propofol. They allowed the label to attach to the channel and then determined attachment points with mass spectrometry. The team plans to test whether mutations to the proposed binding site affect propofol activity in animals.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.